Pittsburgh, PA – According to filings with the U.S. Securities and Exchange Commission, Apollo Neuroscience is raising $15,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Kathryn Fantauzzi played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Apollo Neuroscience
Apollo Neuroscience was co-founded by Dr. David Rabin, MD, PhD and his wife, Kathryn Fantauzzi. Dr. Rabin is a board-certified psychiatrist and neuroscientist who specializes in the treatment of chronic stress. Kathryn, Apollos CEO, specializes in bringing discoveries out of the lab and into the real world. Dr. Rabin began his research on what would become Apollo in 2014 at the University of Pittsburgh. In his clinical work, he noticed a common theme: all of his patients symptoms got worse when they were experiencing stress. Stress sends a signal to our bodies that were under threat. It kicks off our fight-or-flight response and makes it difficult for us to focus, relax and maintain the sleep we need in order to recharge and recover. Dr. Rabin found that deep breathing, biofeedback and meditation are all effective techniques to help manage stress. But unfortunately, these techniques are difficult to do when were already stressed out. Through extensive research, Dr. Rabin noticed that touch was often overlooked in stress management, despite its incredible ability to signal safety to the body and reduce stress. Dr. Rabin discovered that certain waves of vibration can rapidly restore balance to our bodies and minds, while actively improving heart rate variability , a critical measure of the effects of mental and physical stress on the body. After trials in both the lab and in the real world repeatedly demonstrated that Apollo measurably reduces stress, improves focus and helps people sleep, Dr. Rabin and Kathryn joined forces to bring Apollo out of the lab and into the lives of anyone looking for a non-habit forming and safe way to take control of their health.

To learn more about Apollo Neuroscience, visit http://apolloneuro.com/

Contact:
Kathryn Fantauzzi, Chief Executive Officer
518-312-0567
kathryn@apolloneuro.com
https://www.linkedin.com/in/kathryn-fantauzzi-b444ba1a/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved